Early palliative care and overall survival in patients with metastatic upper gastrointestinal cancers (EPIC): a multicentre, open-label, randomised controlled phase 3 trial.

Fiche publication

Date publication

août 2024

Journal

EClinicalMedicine

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BELLETIER Christine , Dr BEN ABDELGHANI Meher , Pr KURTZ Jean-Emmanuel , Dr HENRY Aline

Tous les auteurs :
Adenis A, Da Silva A, Ben Abdelghani M, Bourgeois V, Bogart E, Turpin A, Evin A, Proux A, Galais MP, Jaraudias C, Quintin J, Bouquet G, Samalin E, Bremaud N, Javed S, Henry A, Kurtz JE, Cornuault-Foubert D, Vandamme H, Lucchi E, Pannier D, Belletier C, Paul M, Touzet L, Penel N, Chvetzoff G, Le Deley MC

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39526177

Résumé

Early palliative care (EPC) leads to an improvement in quality of life and an unexpected survival benefit compared with oncological care for patients with metastatic lung cancer. The Early Palliative Integrated Care (EPIC) is aimed at examining whether EPC can improve overall survival in patients with metastatic upper gastrointestinal cancer.